• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 3. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

Introduction to (3S)-4-tert-butoxycarbonyl-6,6-dimethyl-morpholine-3-carboxylic Acid (CAS No. 783349-78-0)

(3S)-4-tert-butoxycarbonyl-6,6-dimethyl-morpholine-3-carboxylic acid, with the CAS number 783349-78-0, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical research and development. This compound belongs to the class of morpholine derivatives, which are widely recognized for their diverse biological activities and potential therapeutic applications. The unique structural features of this molecule, particularly its stereocenter at the 3-position and the presence of a tert-butoxycarbonyl (Boc) protecting group, make it a valuable intermediate in the synthesis of more complex pharmacological agents.

The< strong>Boc group in (3S)-4-tert-butoxycarbonyl-6,6-dimethyl-morpholine-3-carboxylic acid serves as an important protective group for carboxylic acids. This functionality is frequently employed in peptide synthesis and other organic transformations where selective protection and deprotection are crucial. The tert-butyl ester group enhances stability during synthetic processes and can be easily removed under mild acidic conditions, allowing for further functionalization of the molecule.

The stereochemistry of (3S)-4-tert-butoxycarbonyl-6,6-dimethyl-morpholine-3-carboxylic acid is particularly noteworthy. The presence of a single stereocenter at the 3-position contributes to the compound's chiral nature, which is often a critical factor in determining the biological activity of pharmaceutical compounds. Chiral drugs can exhibit different pharmacological properties depending on their enantiomeric form, making the precise control of stereochemistry essential in drug design.

Recent research in the field of morpholine derivatives has highlighted their potential as scaffolds for novel therapeutic agents. Studies have demonstrated that morpholine-based compounds can exhibit a wide range of biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. The structural flexibility of morpholine rings allows for the introduction of various substituents that can modulate biological activity, making them attractive for drug discovery efforts.

In particular, (3S)-4-tert-butoxycarbonyl-6,6-dimethyl-morpholine-3-carboxylic acid has been explored as a building block in the synthesis of peptidomimetics. Peptidomimetics are designed to mimic the bioactivity of natural peptides while offering improved pharmacokinetic properties. The Boc-protected carboxylic acid functionality provides a convenient handle for coupling reactions with amino acids or other nucleophiles, facilitating the construction of complex peptide-like structures.

Advances in synthetic methodologies have further enhanced the utility of (3S)-4-tert-butoxycarbonyl-6,6-dimethyl-morpholine-3-carboxylic acid in drug development. Modern techniques such as asymmetric catalysis and enzymatic resolutions have enabled the efficient preparation of enantiomerically pure forms of this compound. These methods are crucial for ensuring that pharmaceutical candidates exhibit high enantiomeric purity, which is often required for optimal therapeutic efficacy and minimal side effects.

The< strong>dimethyl substitution at the 6-position of (3S)-4-tert-butoxycarbonyl-6,6-dimethyl-morpholine-3-carboxylic acid contributes to the steric environment of the molecule, which can influence its interactions with biological targets. Steric effects play a significant role in determining binding affinity and specificity, making them important considerations in rational drug design. By carefully tailoring these substituents, chemists can optimize the pharmacological profile of morpholine derivatives.

Recent studies have also explored the use of (3S)-4-tert-butoxycarbonyl-6,6-dimethyl-morpholine-3-carboxylic acid in the development of novel antibiotics. The morpholine scaffold has been shown to interfere with bacterial cell wall synthesis and other vital metabolic pathways. Researchers have been particularly interested in its potential to combat multidrug-resistant bacteria, which pose a significant challenge to global health.

The versatility of (3S)-4-tert-butoxycarbonyl-6,6-dimethyl-morpholine-3-carboxylic acid extends beyond its role as a synthetic intermediate. It has also been investigated as a ligand in coordination chemistry, where its ability to form stable complexes with metal ions has been exploited for various applications. These complexes can serve as catalysts or sensors, demonstrating the broad utility of this compound in chemical research.

In conclusion, (3S)-4-tert-butoxycarbonyl-6,6-dimethyl-morpholine-3-carboxylic acid is a multifaceted compound with significant potential in pharmaceutical and chemical research. Its unique structural features make it a valuable tool for synthesizing complex molecules and exploring new therapeutic strategies. As research continues to uncover new applications for morpholine derivatives, compounds like this are likely to play an increasingly important role in drug discovery and development.

• 1439922-07-2(Methyl (R)-4-boc-6,6-dimethyl-morpholine-3-carboxylate)
• 1272758-01-6(Methyl 4-Boc-2,2-dimethyl-morpholine-5-carboxylate)
• 212650-45-8(4-Tert-butyl 3-methyl morpholine-3,4-dicarboxylate)
• 783350-37-8((3S)-4-[(tert-butoxy)carbonyl]morpholine-3-carboxylic acid)
• 869681-70-9((3R)-4-[(tert-butoxy)carbonyl]morpholine-3-carboxylic acid)
• 212650-43-6(4-[(tert-butoxy)carbonyl]morpholine-3-carboxylic acid)
• 1263077-92-4((R)-4-Boc-6,6-Dimethyl-morpholine-3-carboxylic acid)
• 1439922-08-3(Methyl (S)-4-Boc-6,6-dimethyl-morpholine-3-carboxylate)
• 1262408-18-3(4-Tert-Butoxycarbonyl-1,4-oxazepane-3-carboxylic acid)
• 1255098-50-0(4-Boc-6,6-Dimethyl-Morpholine-3-Carboxylic Acid)